JENNIFER BROOKE GOLDSTEIN's research topics

JENNIFER BROOKE GOLDSTEIN

Concepts (63)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with JENNIFER BROOKE GOLDSTEIN's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JENNIFER BROOKE GOLDSTEIN has written about over time.

Mass Screening, 1 publications between 2009 and 2009, average publication date June 2009. alpha-Glucosidases, 2 publications between 2009 and 2012, average publication date October 2010. Glycogen Storage Disease Type II, 2 publications between 2009 and 2012, average publication date October 2010. Muscle, Skeletal, 2 publications between 2009 and 2012, average publication date October 2010. Glycogen, 1 publications between 2012 and 2012, average publication date January 2012. Colorectal Neoplasms, 1 publications between 2014 and 2014, average publication date February 2014. Microsatellite Instability, 1 publications between 2014 and 2014, average publication date February 2014. Adenocarcinoma, Follicular, 1 publications between 2015 and 2015, average publication date February 2015. Dermatitis, Photoallergic, 1 publications between 2015 and 2015, average publication date February 2015. Everolimus, 1 publications between 2015 and 2015, average publication date February 2015. Protein-Tyrosine Kinases, 1 publications between 2015 and 2015, average publication date February 2015. Thyroid Neoplasms, 1 publications between 2015 and 2015, average publication date February 2015. Liver Neoplasms, 2 publications between 2014 and 2016, average publication date March 2015. Rare Diseases, 1 publications between 2016 and 2016, average publication date April 2016. Sialic Acid Storage Disease, 1 publications between 2016 and 2016, average publication date April 2016. Antineoplastic Agents, 2 publications between 2015 and 2019, average publication date March 2017. Piperidines, 2 publications between 2015 and 2019, average publication date March 2017. Quinazolines, 2 publications between 2015 and 2019, average publication date March 2017. Dermatitis, Phototoxic, 1 publications between 2019 and 2019, average publication date April 2019. Drug Eruptions, 1 publications between 2019 and 2019, average publication date April 2019.

Mass Screening
alpha-Glucosidases
Glycogen Storage Disease Type II
Muscle, Skeletal
Glycogen
Colorectal Neoplasms
Microsatellite Instability
Adenocarcinoma, Follicular
Dermatitis, Photoallergic
Everolimus
Protein-Tyrosine Kinases
Thyroid Neoplasms
Liver Neoplasms
Rare Diseases
Sialic Acid Storage Disease
Antineoplastic Agents
Piperidines
Quinazolines
Dermatitis, Phototoxic
Drug Eruptions

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Mass Screening	1	2009	2009	June 2009
alpha-Glucosidases	2	2009	2012	October 2010
Glycogen Storage Disease Type II	2	2009	2012	October 2010
Muscle, Skeletal	2	2009	2012	October 2010
Glycogen	1	2012	2012	January 2012
Colorectal Neoplasms	1	2014	2014	February 2014
Microsatellite Instability	1	2014	2014	February 2014
Adenocarcinoma, Follicular	1	2015	2015	February 2015
Dermatitis, Photoallergic	1	2015	2015	February 2015
Everolimus	1	2015	2015	February 2015
Protein-Tyrosine Kinases	1	2015	2015	February 2015
Thyroid Neoplasms	1	2015	2015	February 2015
Liver Neoplasms	2	2014	2016	March 2015
Rare Diseases	1	2016	2016	April 2016
Sialic Acid Storage Disease	1	2016	2016	April 2016
Antineoplastic Agents	2	2015	2019	March 2017
Piperidines	2	2015	2019	March 2017
Quinazolines	2	2015	2019	March 2017
Dermatitis, Phototoxic	1	2019	2019	April 2019
Drug Eruptions	1	2019	2019	April 2019

GOLDSTEIN's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (63)

Explore

Co-Authors (10)

Explore

Similar People (60)

Explore

Same Department

Explore